ConductScience.org, home

Paper36912188

Characterization of immune cell populations in syngeneic murine tumor models.

Snipstad S and 3 others. Cancer Med, 2023. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Characterization of immune cell populations in syngeneic murine tumor models. Papers, record 36912188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36912188

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of immune cell populations in syngeneic murine tumor models.
PubMed
Journal
Cancer Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2023-06-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Snipstad SSofie
2Bremnes FFrida
3Dehli Haugum MMats
4Sulheim EEinarhttps://orcid.org/0000-0003-3918-3345

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
T-LymphocytesMajor topic
Colonic NeoplasmsMajor topic
Animals
Mice
Tumor Microenvironment
Cell Line, Tumor
Immunotherapy
Disease Models, Animal

Source PubMed

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,819,064The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.Cancer Immunol Res2017https://conductscience.org/library/papers/28819064PubMed
236,912,188Characterization of immune cell populations in syngeneic murine tumor models.Cancer Med2023https://conductscience.org/library/papers/36912188PubMed
324,277,834Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24277834PubMed
418,432,775Mouse 4T1 breast tumor model.Curr Protoc Immunol2001https://conductscience.org/library/papers/18432775PubMed
525,979,873Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.Cancer Res2015https://conductscience.org/library/papers/25979873PubMed
627,248,578Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.Curr Protoc Pharmacol2016https://conductscience.org/library/papers/27248578PubMed
732,179,637Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.J Immunol2020https://conductscience.org/library/papers/32179637PubMed
829,684,498Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models.J Control Release2018https://conductscience.org/library/papers/29684498PubMed
930,610,226Approaches to treat immune hot, altered and cold tumours with combination immunotherapies.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30610226PubMed
1030,356,816The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent.Front Immunol2018https://conductscience.org/library/papers/30356816PubMed
1125,888,329Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.Gastroenterology2015https://conductscience.org/library/papers/25888329PubMed
121,255,804Murine colon adenocarcinomas: methods for selective culture in vitro.J Natl Cancer Inst1976https://conductscience.org/library/papers/1255804PubMed
1330,309,862Mouse Models for Cancer Immunotherapy Research.Cancer Discov2018https://conductscience.org/library/papers/30309862PubMed
1428,302,645PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.J Exp Med2017https://conductscience.org/library/papers/28302645PubMed
1531,779,705Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery.J Immunother Cancer2019https://conductscience.org/library/papers/31779705PubMed
1630,388,137Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments.PLoS One2018https://conductscience.org/library/papers/30388137PubMed
1712,946,314Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.Mol Ther2003https://conductscience.org/library/papers/12946314PubMed
1824,991,577The roles of regulatory B cells in cancer.J Immunol Res2014https://conductscience.org/library/papers/24991577PubMed
1931,200,747B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.J Immunother Cancer2019https://conductscience.org/library/papers/31200747PubMed
2028,569,770Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.Cell Death Dis2017https://conductscience.org/library/papers/28569770PubMed

See all 30 references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42,564,443A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse immunosuppressive profiles.Front Immunol2026https://conductscience.org/library/papers/42564443PubMed
42,251,180The electrical and chemical hypoxia-optimized (ECHO) bioreactor system enables scalable production of functionally preserved NK-exosomes validated in a syngeneic lung cancer model.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42251180PubMed
42,162,232Tumor implantation site dictates the immune landscape of syngeneic mouse models of head and neck cancer.Sci Rep2026https://conductscience.org/library/papers/42162232PubMed
41,961,275Challenges in tracer development for tumor microenvironment (TME) imaging.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/41961275PubMed
41,624,403Virus-based IFNγ gene delivery and photodynamic therapy cooperate to remodel the tumor microenvironment and suppress breast cancer.Mol Ther Oncol2026https://conductscience.org/library/papers/41624403PubMed
41,322,421Single-cell atlas of the tumor immune microenvironment across syngeneic murine models.Front Immunol2025https://conductscience.org/library/papers/41322421PubMed
41,205,593Developing a therapeutic elastase that stimulates anti-tumor immunity by selectively killing cancer cells.Cell Rep Med2025https://conductscience.org/library/papers/41205593PubMed
41,148,819The Immunomodulatory Role of Gemcitabine in Triple Negative Breast Cancer.Cells2025https://conductscience.org/library/papers/41148819PubMed
41,130,795PET Imaging of System A Amino Acid Transport Detects Early Response to Immune Checkpoint Inhibitor Therapy in a Syngeneic Mouse Model.J Nucl Med2025https://conductscience.org/library/papers/41130795PubMed
40,707,495The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer.NPJ Breast Cancer2025https://conductscience.org/library/papers/40707495PubMed
40,403,728Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis.Cell2025https://conductscience.org/library/papers/40403728PubMed
40,026,631Lymph node-targeted delivery of Lonicera japonica thunb. polysaccharides for enhancing antitumor immunotherapy.Mater Today Bio2025https://conductscience.org/library/papers/40026631PubMed
39,708,807Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes.Cell2025https://conductscience.org/library/papers/39708807PubMed
39,250,241Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.Cancer Res2024https://conductscience.org/library/papers/39250241PubMed
38,918,836Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.Breast Cancer Res2024https://conductscience.org/library/papers/38918836PubMed
38,515,636Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines.BME Front2024https://conductscience.org/library/papers/38515636PubMed
36,912,188Characterization of immune cell populations in syngeneic murine tumor models.Cancer Med2023https://conductscience.org/library/papers/36912188PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36912188

GET https://conductscience.org/api/papers/v1/36912188/references?page=2